Triethylamine → [2-(5-Phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyridin-3-yl]-(1,1,3,3-tetramethyl-butyl)-amine

HRID 29103

Reaktionsgleichung

Reaktionsgleichung von HRID 29103
Br[C:2]1[S:6][C:5]([C:7]2[N:8]=[C:9]3[CH:14]=[CH:13][CH:12]=[CH:11][N:10]3[C:15]=2[NH:16][C:17]([CH3:24])([CH3:23])[CH2:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[CH:4][CH:3]=1.[C:25]1([C:31]#[CH:32])[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1.C(N(CC)CC)C.C(=O)([O-])[O-].[Na+].[Na+]>CN(C=O)C.CC(=O)OCC.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[Cu]I>[C:25]1([C:31]#[C:32][C:2]2[S:6][C:5]([C:7]3[N:8]=[C:9]4[CH:14]=[CH:13][CH:12]=[CH:11][N:10]4[C:15]=3[NH:16][C:17]([CH3:23])([CH3:24])[CH2:18][C:19]([CH3:20])([CH3:22])[CH3:21])=[CH:4][CH:3]=2)[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1

Komponenten

9

Edukt 4

HCID 8471TriethylamineHCID 10340Sodium CarbonateHCID 10821PhenylacetyleneHCID 69317913[2-(5-Bromothiophen-2-yl)-imidazo[1,2-a]pyridin-3-yl]-(1,1,3,3-tetramethyl-butyl)-amine

Produkt 1

HCID 11604327[2-(5-Phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyridin-3-yl]-(1,1,3,3-tetramethyl-butyl)-amineAusbeute 16,2 %

Reagenzien, Katalysatoren, Lösungsmittel 4

HCID 24350Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)KatalysatorHCID 178418476HCID 178418476, VerbindungKatalysatorHCID 6228DimethylformamideLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Reaktionsbedingungen

Temperatur
50 °C

Versuchsvorschrift

324 mg (0.80 mmol) of [2-(5-bromothiophen-2-yl)-imidazo[1,2-a]pyridin-3-yl]-(1,1,3,3-tetramethyl-butyl)-amine were dissolved together with 0.11 ml (0.96 mmol) of phenylacetylene, 14 mg (0.02 mmol) of bis(triphenylphosphine)-palladium(II) chloride and 7 mg (0.04 mmol) of copper(I) iodide in DMF (6 ml) After addition of 1.1 ml (8.0 mmol) of triethylamine, the mixture was stirred at 50° C. for 2 d. The reaction solution was then diluted with EA and combined with a sat. aq. sodium carbonate solution. The phases were separated and the aqueous phase extracted with EA. The combined organic phases were washed 2× with a sat. aq. sodium carbonate solution and 2× with a sat. aq. common salt solution and dried over magnesium sulfate. After filtration and removal of the solvents under a vacuum, column chromatography (EA/DIPE/DCM 3:3:4) was carried out with the group, after which 54 mg (0.13 mmol, 16% of theoretical) of [2-(5-phenylethynyl-thiophen-2-yl)-imidazo[1,2-a]pyridin-3-yl]-(1,1,3,3-tetramethyl-butyl)-amine were obtained.

Aufarbeitung

  1. customThe phases were separated
  2. extractionthe aqueous phase extracted with EA
  3. washThe combined organic phases were washed 2× with a sat. aq. sodium carbonate solution and 2× with a sat. aq. common salt solution
  4. dry with materialdried over magnesium sulfate
  5. filtrationAfter filtration and removal of the solvents under a vacuum, column chromatography (EA/DIPE/DCM 3:3:4)

Quellen und Nachweise

ORD-Eintrag
ord-197ca6f2a6c847a78ca3f34e71ca64f8
Quelldatensatz
uspto-grants-2008_09
Patentnummer
US07420056B2

Verknüpfte Notizen

Wird geladen…